976 related articles for article (PubMed ID: 32029896)
1. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
[TBL] [Abstract][Full Text] [Related]
2. Acetylation promotes BCAT2 degradation to suppress BCAA catabolism and pancreatic cancer growth.
Lei MZ; Li XX; Zhang Y; Li JT; Zhang F; Wang YP; Yin M; Qu J; Lei QY
Signal Transduct Target Ther; 2020 May; 5(1):70. PubMed ID: 32467562
[TBL] [Abstract][Full Text] [Related]
3. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.
Mayers JR; Torrence ME; Danai LV; Papagiannakopoulos T; Davidson SM; Bauer MR; Lau AN; Ji BW; Dixit PD; Hosios AM; Muir A; Chin CR; Freinkman E; Jacks T; Wolpin BM; Vitkup D; Vander Heiden MG
Science; 2016 Sep; 353(6304):1161-5. PubMed ID: 27609895
[TBL] [Abstract][Full Text] [Related]
4. Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization.
Li JT; Li KY; Su Y; Shen Y; Lei MZ; Zhang F; Yin M; Chen ZJ; Wen WY; Hu WG; Su D; Qu J; Lei QY
Natl Sci Rev; 2022 May; 9(5):nwab212. PubMed ID: 35663242
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism.
Lee JH; Cho YR; Kim JH; Kim J; Nam HY; Kim SW; Son J
Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31784505
[TBL] [Abstract][Full Text] [Related]
6. GEO data mining and TCGA analysis reveal altered branched chain amino acid metabolism in pancreatic cancer patients.
Li JY; Sun F; Yang CL; Zhou HF; Gao M; Zhang Q; Chen H; Zhou P; Xiao J; Fan H
Aging (Albany NY); 2021 Apr; 13(8):11907-11918. PubMed ID: 33882453
[TBL] [Abstract][Full Text] [Related]
7. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.
Dey P; Baddour J; Muller F; Wu CC; Wang H; Liao WT; Lan Z; Chen A; Gutschner T; Kang Y; Fleming J; Satani N; Zhao D; Achreja A; Yang L; Lee J; Chang E; Genovese G; Viale A; Ying H; Draetta G; Maitra A; Wang YA; Nagrath D; DePinho RA
Nature; 2017 Feb; 542(7639):119-123. PubMed ID: 28099419
[TBL] [Abstract][Full Text] [Related]
8. Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.
Singh K; Pruski M; Bland R; Younes M; Guha S; Thosani N; Maitra A; Cash BD; McAllister F; Logsdon CD; Chang JT; Bailey-Lundberg JM
Lab Invest; 2021 Feb; 101(2):177-192. PubMed ID: 33009500
[TBL] [Abstract][Full Text] [Related]
9. CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth.
Wang VM; Ferreira RMM; Almagro J; Evan T; Legrave N; Zaw Thin M; Frith D; Carvalho J; Barry DJ; Snijders AP; Herbert E; Nye EL; MacRae JI; Behrens A
Nat Cell Biol; 2019 Nov; 21(11):1425-1435. PubMed ID: 31685994
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development.
Kang ZR; Jiang S; Han JX; Gao Y; Xie Y; Chen J; Liu Q; Yu J; Zhao X; Hong J; Chen H; Chen YX; Chen H; Fang JY
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166941. PubMed ID: 37926361
[TBL] [Abstract][Full Text] [Related]
11. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
12. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL4 accelerates KRAS
Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
[TBL] [Abstract][Full Text] [Related]
14. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
15. Expanding the genetic and phenotypic spectrum of branched-chain amino acid transferase 2 deficiency.
Knerr I; Colombo R; Urquhart J; Morais A; Merinero B; Oyarzabal A; Pérez B; Jones SA; Perveen R; Preece MA; Rogers Y; Treacy EP; Mayne P; Zampino G; MacKinnon S; Wassmer E; Yue WW; Robinson I; Rodríguez-Pombo P; Olpin SE; Banka S
J Inherit Metab Dis; 2019 Sep; 42(5):809-817. PubMed ID: 31177572
[TBL] [Abstract][Full Text] [Related]
16. Development of thymic tumor in [LSL:Kras
Liot S; El Kholti N; Balas J; Genestier L; Verrier B; Valcourt U; Lambert E
Sci Rep; 2021 Jul; 11(1):15075. PubMed ID: 34302028
[TBL] [Abstract][Full Text] [Related]
17. Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours.
Zhu Z; Achreja A; Meurs N; Animasahun O; Owen S; Mittal A; Parikh P; Lo TW; Franco-Barraza J; Shi J; Gunchick V; Sherman MH; Cukierman E; Pickering AM; Maitra A; Sahai V; Morgan MA; Nagrath S; Lawrence TS; Nagrath D
Nat Metab; 2020 Aug; 2(8):775-792. PubMed ID: 32694827
[TBL] [Abstract][Full Text] [Related]
18. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
19. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.
Philip B; Roland CL; Daniluk J; Liu Y; Chatterjee D; Gomez SB; Ji B; Huang H; Wang H; Fleming JB; Logsdon CD; Cruz-Monserrate Z
Gastroenterology; 2013 Dec; 145(6):1449-58. PubMed ID: 23958541
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.
Shi G; DiRenzo D; Qu C; Barney D; Miley D; Konieczny SF
Oncogene; 2013 Apr; 32(15):1950-8. PubMed ID: 22665051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
